CD4 and neoplasm: In the H22 hepatocellular carcinoma model, Coumarin effectively inhibits tumor growth by enhancing NK cell functions and increasing the infiltration ratios of immune cells (NK cells, CD4+ T cells, and CD8+ T cells) in the tumor microenvironment, thereby exerting its immunomodulatory antitumor effects.